Literature DB >> 6785232

Purification and characterization of two components of botulinum C2 toxin.

I Ohishi, M Iwasaki, G Sakaguchi.   

Abstract

Two dissimilar proteins, designated as components I and II, of botulinum C2 toxin elaborated by strain 92-13 were purified to a homogeneous state. The molecular weights determined by sodium dodecyl sulfate gel electrophoresis were 55,000 for component I and 105,000 for component II. Whereas each component showed no or feeble toxicity even after being treated with trypsin, the toxicity was elicited when these two components were mixed and trypsinized. The toxicity of the mixture of components I and II at a ratio of 1:2.5 on a protein basis was 2.2 X 10(4) mouse intraperitoneal 50% lethal doses per mg of protein and increased by 2,000 times or more when treated with trypsin. These results indicate that the molecular characteristics of botulinum C2 toxin differ from those of the toxin of Clostridium botulinum types A through F in that C2 toxin is constructed with two separate protein components, which are not covalently held together, and that its toxicity is elicited by cooperation of the two components.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6785232      PMCID: PMC551367          DOI: 10.1128/iai.30.3.668-673.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Activation of a toxic component of Clostridium botulinum types C and D by trypsin.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1972-07

3.  Disulfide-toxicity relationship of botulinal toxin types A, E, and F.

Authors:  H Sugiyama; R Das Gupta; K H Yang
Journal:  Proc Soc Exp Biol Med       Date:  1973-07

4.  A common subunit structure in Clostridium botulinum type A, B and E toxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

5.  The toxic antigenic factors produced by Clostridium botulinum types C and D.

Authors:  B C Jansen
Journal:  Onderstepoort J Vet Res       Date:  1971-06       Impact factor: 1.792

6.  Purification and some properties of Clostridium botulinum type-E toxin.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  Biochim Biophys Acta       Date:  1968-10-21

7.  Tryptic activation of Clostridium botulinum type C beta toxin.

Authors:  B C Jansen; P C Knoetze
Journal:  Onderstepoort J Vet Res       Date:  1971-12       Impact factor: 1.792

8.  Observations on molecular weight determinations on polyacrylamide gel.

Authors:  A K Dunker; R R Rueckert
Journal:  J Biol Chem       Date:  1969-09-25       Impact factor: 5.157

9.  Antigenicites of fragments of Clostridium botulinum type B derivative toxin.

Authors:  S Kozaki; G Sakaguchi
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

10.  Isolation and molecular size of Clostridium botulinum type C toxin.

Authors:  B Syuto; S Kubo
Journal:  Appl Environ Microbiol       Date:  1977-02       Impact factor: 4.792

View more
  67 in total

1.  New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.

Authors:  H Genth; J Selzer; C Busch; J Dumbach; F Hofmann; K Aktories; I Just
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding.

Authors:  D Blöcker; H Barth; E Maier; R Benz; J T Barbieri; K Aktories
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Visualizations of binding and internalization of two nonlinked protein components of botulinum C2 toxin in tissue culture cells.

Authors:  I Ohishi; A Yanagimoto
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

4.  The host cell chaperone Hsp90 is necessary for cytotoxic action of the binary iota-like toxins.

Authors:  Gerd Haug; Klaus Aktories; Holger Barth
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Adenosine diphosphate-ribosylation of G-actin by botulinum C2 toxin increases endothelial permeability in vitro.

Authors:  N Suttorp; M Polley; J Seybold; H Schnittler; W Seeger; F Grimminger; K Aktories
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 6.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

Review 7.  Clostridial ADP-ribosyltransferases--modification of low molecular weight GTP-binding proteins and of actin by clostridial toxins.

Authors:  K Aktories
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

8.  Production by Clostridium spiroforme of an iotalike toxin that possesses mono(ADP-ribosyl)transferase activity: identification of a novel class of ADP-ribosyltransferases.

Authors:  L L Simpson; B G Stiles; H Zepeda; T D Wilkins
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

9.  Inhibition of the contraction of the isolated longitudinal muscle of the guinea-pig ileum by botulinum C2 toxin: evidence for a role of G/F-actin transition in smooth muscle contraction.

Authors:  S Mauss; G Koch; V A Kreye; K Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

10.  ADP-ribosylation of Drosophila indirect-flight-muscle actin and arthrin by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin.

Authors:  I Just; E S Hennessey; D R Drummond; K Aktories; J C Sparrow
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.